Definitive Contract HHSN275201700001C
- Not listed
- The National Institute on Alcohol Abuse and Alcoholism (NIAAA), a civilian agency within the National Institutes of Health (NIH), awarded a $998,800 Small Business Innovation Research (SBIR) Phase II contract to Dexorgen Inc., a minority-owned and self-certified small disadvantaged business doing business as Codex Biosolutions Inc. The contract is for the development of novel phosphodiesterase 4B (PDE4B) inhibitors to treat alcohol use disorder. This is a cost-plus-fixed-fee definitive...
- This $18,000 firm fixed price purchase order was awarded by the National Institutes of Health's National Institute on Drug Abuse to Codex Biosolutions Inc., a minority-owned small business located in Gaithersburg, Maryland. Codex Biosolutions provides cell-based assay products and services to support research and development activities for government agencies, pharmaceutical companies, and other institutes. Under this contract, Codex is tasked with delivering specialized cell lines,...
- This contract was awarded by the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases to Codex Biosolutions Inc., a minority-owned small disadvantaged business, to identify cellular factors that impact the production of a full-length HIV-1 envelope trimer without altering its native antigenic properties. The $599,424.00 firm-fixed-price contract is funded through the Small Business Innovation Research (SBIR) program and...
- This federal contract was awarded by the Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse to Codex Biosolutions Inc., a minority-owned small business located in Gaithersburg, Maryland. The $15,100 firm fixed-price purchase order contract is for Codex Biosolutions to provide research and development services, including generating custom cell lines and supplying pseudovirus particles and stable cell lines expressing SARS-CoV-2 variants to...
- This award is for a Small Business Innovation Research (SBIR) Phase I contract to Netrias, LLC, a small business that specializes in AI-driven data harmonization for the life sciences industry. The $224,865 contract was awarded by the Department of Health and Human Services National Institutes of Health National Institute of Child Health and Human Development to provide services for synthesizing information to support treatments for alcohol use disorder. This contract is part of the NIH and...
- This contract was awarded by the National Institutes of Health (NIH) National Center for Advancing Translational Sciences to Codex Biosolutions Inc., a minority-owned small business located in Gaithersburg, Maryland. The $18,060 firm fixed-price purchase order is for screening services to identify small molecule antagonists of the GPR17 receptor, which is involved in various diseases. Codex Biosolutions specializes in cell-based assays and has received numerous NIH contracts for research and...
- The National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the Department of Health and Human Services' National Institutes of Health, awarded a $30,000.00 firm fixed-price purchase order to BDX Research & Consulting LLC, a minority-owned, small disadvantaged business, for principal consultant services. This award was made on a non-competitive sole source basis as a follow-on to a pre-solicitation notice issued by the National Institute of Child Health and Human Development...
- This federal contract award to Dexorgen Inc., doing business as Codex Biosolutions Inc., was issued by the National Center for Advancing Translational Sciences (NCATS), a civilian agency under the National Institutes of Health (NIH). The $24,000.00 firm-fixed price purchase order is for the "GENERATION AND CHARACTERIZATION IPSC DERIVED BRAIN ORGANOIDS FROM BAIN TYPE X-LINKED MENTAL RETARDATION SYNDROME (MRXSB)". Codex Biosolutions is a minority-owned small disadvantaged business that...
- This is a Firm Fixed Price Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Child Health and Human Development (NICHD), a civilian federal agency, to Astraea Therapeutics LLC, a woman-owned small business. The contract, valued at $297,170.00, is for research on Nociceptin Receptor (NOP) Agonists for Alcohol Use Disorders. The contract has an ultimate completion date of April 30, 2014. As an SBIR Phase I contract, this effort is focused on...
- This is a $200,000.00 Firm Fixed Price Definitive Contract awarded by the National Institute of Child Health and Human Development (NICHD), a civilian federal agency, to Therasource LLC, a minority-owned, for-profit limited liability company. The contract is for research and development in the area of "Biomedical (Applied Research/Exploratory Development)" under the Small Business Innovation Research (SBIR) Program Phase II. The contract is focused on "Alcohol-Induced Injury and...
The Department of Health and Human Services National Institutes of Health National Institute of Child Health and Human Development awarded Codex Biosolutions Inc., a small disadvantaged and minority-owned business, a firm fixed-price Small Business Innovation Research (SBIR) Phase I contract for the "DEVELOPMENT OF NOVEL PDE4B INHIBITORS TO TREAT ALCOHOL USE DISORDER" worth $224,656.00. As the prime contractor, Codex Biosolutions will provide specialized bioengineering, genomic screening, and drug testing services to support translational medicine initiatives across the National Institutes of Health, including the National Institute on Alcohol Abuse and Alcoholism, National Institute of Allergy and Infectious Diseases, National Institute on Drug Abuse, and National Center for Advancing Translational Sciences.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 1 | Other Administrative Action | $0 | 6/5/18 | |
| Not listed | Not listed | $224.7k | 6/7/17 |